Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Nextech3D.ai Announces Enterprise 3D Modeling Deal With AI Revenue Driving Growth (click to learn more)
Biosenta's Tri-Filler(TM) Nanoparticles Achieve 100% Killing of Pathogens (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Revelation Biosciences Inc
REVB
Healthcare
Biotechnology
Revelation Biosciences, Inc. is a clinical-stage life sciences company engaged in the development of innate immune system therapeutics and diagnostics. Its therapeutic candidates are based on its Gemini formulation of active ingredient phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA) that is known to stimulate Toll-like receptor 4 (TLR-4). Its...
product candidates include Gemini-SSI, which is being developed for the prevention and treatment of surgical sit infection; Gemini-AKI, which is being developed as a potential therapy for the prevention and treatment of acute kidney injury as a result of cardiac surgery; and Gemini-CKD, which is being developed as a potential therapy for the prevention and treatment of chronic kidney disease. Stimulation of TLR4 via Gemini leads to a controlled production of varied cytokines and chemokines which modulate the activity of the innate and adaptive immune response, relative to Lipopolysaccharides (LPS).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:REVB)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
Next
(109)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 07, 2024 12:07pm
REVB.....still on watch
No position Maybe sub $3...small
(109)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 04, 2024 9:24am
REVB..... NR on watch list $3.60 ; )
Revelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of Gemini 2024-03-04 06:00 ET - News Release -Top-line data including safety,
...more
Mullen Group Closes Acquisition of Cole Group of Companies
posted Jun 12, 2025 9:00am by
Mullen Group Ltd.
-
|
Cole Group is expected to generate annualized revenues of approximately $300.0 million and operating income before depreciation and amortization ("OIBDA") of $20.0 million. Cole Group operates a non-asset based business and has minimal capital expenditure requirements. ...read more
(0)
•••
PressRelease
X
Post by
PressRelease
on Mar 04, 2024 9:09am
New Press Release - Revelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of Gemini
-Top-line data including safety, tolerability, and biomarker activity anticipated this summer--This Phase 1 clinical study data will support further development across multiple indications- Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”) a clinical-stage life sciences...
read article.
(109)
•••
Iseneschal
X
Post by
Iseneschal
on Feb 14, 2024 1:28pm
REVB..... I wish I owned some paper ...just sayin $3.05
But I don't Might take a position if any weakness My gut is talking to me .....maybe I'm hungry for a nice Steak & Eggs Breakfast ; )
(0)
•••
PressRelease
X
Post by
PressRelease
on Feb 13, 2024 9:07am
New Press Release - Revelation Biosciences Inc. Receives Invitation to Give an Oral Presentation at The 29th International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)
– Oral presentation in addition to poster presentation announced January 30, 2024 – Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), announced today that, as part of a limited number of accepted abstract authors, the company was invited to give an oral presentation of...
read article.
(109)
•••
Iseneschal
X
Post by
Iseneschal
on Feb 06, 2024 1:06pm
REVB.... I just had a "Revelation"....bot a starter position
$2.83....I hope this drops Will add......sub $2.50 ; )
(0)
•••
PressRelease
X
Post by
PressRelease
on Feb 05, 2024 4:41pm
New Press Release - Revelation Biosciences Inc. Announces Closing of $6.2 Million Public Offering
Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, today announced the closing on February 5, 2024 of its previously announced public offering...
read article.
(109)
•••
Iseneschal
X
Post by
Iseneschal
on Feb 02, 2024 12:51pm
REVB....just watching Mr.M put the screws to every1
Drop this pig
(109)
•••
Iseneschal
X
Comment by
Iseneschal
on Feb 01, 2024 9:00am
RE:REVB....You're all going to get screwed....again
You were all warned....P.O announced this a.m Revelation Biosciences Inc. Announces Pricing of $6.2 Million Public Offering-02-01 03:00 ET - News Release SAN DIEGO -- (Business Wire)
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Feb 01, 2024 6:02am
New Press Release - Revelation Biosciences Inc. Announces Pricing of $6.2 Million Public Offering
Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, today announced the pricing of a public offering of 1,365,000 shares of its common stock (or...
read article.
(109)
•••
Iseneschal
X
Comment by
Iseneschal
on Jan 31, 2024 3:33pm
RE:RE:REVB ...Oh Boy...u can drive a Mac Truck
LoL....even if you bot this sub $8.....Mr. M makes sure u can't off your paper for a profit.....what a Dbag he is
(109)
•••
Iseneschal
X
Comment by
Iseneschal
on Jan 31, 2024 3:28pm
RE:REVB ...Oh Boy...u can drive a Mac Truck
And Zero Volume....now that is ridiculous
(109)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 31, 2024 3:27pm
REVB ...Oh Boy...u can drive a Mac Truck
between the bid and Ask
(109)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 31, 2024 3:26pm
REVB ...last 1/2 hour heroics.....any Chasers out there??
Go ahead....I dare ya
(109)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 31, 2024 12:15pm
REVB...All I can say is....That I really have a tough time
realizing very well that this industry preys on the unsuspecting people that have worked hard for their money and in a few hours can literally be wiped out buy this system. It's an unlevel
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Despite turbulent markets this logistics company continues to grow
Merger Announced to Create a Leading Yukon Copper-Gold Exploration and Development Company
Graphite One and Lucid Enter into Second Non-Binding Supply Agreement
Graphite Creek Project Approved for FAST-41 Federal Permitting Dashboard
Mullen Group acquires company expected to generate annualized revenues of $300 million